- Sixth New Director Since 2017 as Part of Allergan's Transformation from a Generic to a Branded Biopharmaceutical Company -
- Company to Recommend FOR a Shareholder Proposal to Phase In Independent Board Chair at Next Leadership Transition -
PR Newswire
DUBLIN, Feb. 19, 2019